Not really correct.... plans for expansion are significant and the product is still tops in its category...now with fingers pointing to pesticides as the reasoning for the bump in birth defects, WFM is a stronger player than ever before. This is a buy opportunity prior to a split.
Are you kidding me? Earnings for year are going to be around $1.30. Forward P/E in the 40's with lowered 2014 guidance. This is as bad as CMG with equally bad long term prospects. Even the hyperbolic Cramer got this one right a year or so ago. Based on pre-reverse split, WFM, on the high end, should be a $75 stock w/ $2.50 earnings, e.g. P/E of 25. It is far beyond that now as adjusted-even after the drop presently-is $118'ish w/ earnings of $2.60'ish. Very realistically, this could see the $40's by Nov option expiration.
Sentiment: Strong Sell
In your opinion "It shoud be up....", but in reality.....
Share price is partially based on expectations and when said expectations are not met...
Those two are not opinions, but reality.
The market is reacting (somewhat) appropriately.